464 related articles for article (PubMed ID: 29187232)
1. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
[TBL] [Abstract][Full Text] [Related]
2. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients.
Link A; Klingele M; Speer T; Rbah R; Pöss J; Lerner-Gräber A; Fliser D; Böhm M
Crit Care; 2012 May; 16(3):R97. PubMed ID: 22643456
[TBL] [Abstract][Full Text] [Related]
3. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
[TBL] [Abstract][Full Text] [Related]
6. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
Zhang W; Bai M; Yu Y; Li L; Zhao L; Sun S; Chen X
Crit Care; 2019 Jan; 23(1):22. PubMed ID: 30678706
[TBL] [Abstract][Full Text] [Related]
8. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
Rodriguez K; Srivaths PR; Tal L; Watson MN; Riley AA; Himes RW; Desai MS; Braun MC; Akcan Arikan A
PLoS One; 2017; 12(8):e0182134. PubMed ID: 28792509
[TBL] [Abstract][Full Text] [Related]
9. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
10. Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study.
Yu Y; Peng S; Cen Z; Cai J; Wang W; Tang Y; Du M; Liu Z; Chang P
Kidney Blood Press Res; 2018; 43(4):1065-1074. PubMed ID: 29969768
[TBL] [Abstract][Full Text] [Related]
11. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
Oudemans-van Straaten HM
Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation in critically ill patients with liver and kidney failure.
Balogun RA; Turgut F; Caldwell S; Abdel-Rahman EM
J Nephrol; 2012; 25(1):113-9. PubMed ID: 21607918
[TBL] [Abstract][Full Text] [Related]
13. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.
Fisher R; Lei K; Mitchell MJ; Moore GW; Dickie H; Tovey L; Crichton S; Ostermann M
BMC Nephrol; 2017 Oct; 18(1):304. PubMed ID: 28969597
[TBL] [Abstract][Full Text] [Related]
14. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.
Oudemans-van Straaten HM; Ostermann M
Crit Care; 2012 Dec; 16(6):249. PubMed ID: 23216871
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors for citrate accumulation in patients with liver failure undergoing continuous renal replacement therapy with regional citrate anticoagulation].
Lin J; Tian L; Wang Y; Ren K; Cao Z; Zhang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):211-215. PubMed ID: 33729142
[TBL] [Abstract][Full Text] [Related]
16. Regional citrate anticoagulation for continuous renal replacement therapy in children.
Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience.
Pertica N; Cicciarella L; Carraro A; Montin U; Violi P; Lupo A; Zaza G
Transplant Proc; 2017 May; 49(4):674-676. PubMed ID: 28457369
[TBL] [Abstract][Full Text] [Related]
18. Bone resorption and "relative" immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation.
Wang PL; Meyer MM; Orloff SL; Anderson S
Am J Kidney Dis; 2004 Dec; 44(6):1110-4. PubMed ID: 15558534
[TBL] [Abstract][Full Text] [Related]
19. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
[TBL] [Abstract][Full Text] [Related]
20. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Focus on citrate accumulation.
Persic V; Vajdic Trampuz B; Medved B; Pavcnik M; Ponikvar R; Gubensek J
Artif Organs; 2020 May; 44(5):497-503. PubMed ID: 31851381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
